請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/50567完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 林先和 | |
| dc.contributor.author | Chen-Hao Lo | en |
| dc.contributor.author | 羅振豪 | zh_TW |
| dc.date.accessioned | 2021-06-15T12:46:32Z | - |
| dc.date.available | 2018-08-31 | |
| dc.date.copyright | 2016-08-26 | |
| dc.date.issued | 2016 | |
| dc.date.submitted | 2016-07-25 | |
| dc.identifier.citation | 1. 衛生福利部疾病管制署(2015), 傳染病統計資料查詢系統。 Retrieved May 30, 2016, from http://nidss.cdc.gov.tw/ch/
2. Murray, C.J., Quantifying the Burden of Disease - the Technical Basis for Disability-Adjusted Life Years. Bulletin of the World Health Organization, 1994, 72 (3): 429-445. 3. Murray, C.J., Lopez A.D. and Jamison D.T., The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bulletin of the World Health Organization, 1994, 72 (3): 495-509. 4. Vos, T., Barber, R.M., Bell, B., Bertozzl-Villa, A., Biryukov, S., Bolliger, I., et al., Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Aug 22;386(9995):743-800. 5. Murray, C.J., Barber, R.M., Foreman, K.J., Ozgoren, A.A., Abd-Allah, F., Abera, S.F., et al., Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet. 2015 Nov 28;386(10009):2145-91. 6. Flaxman, A.D., Vos, T. and Murray, C.J., An Integrative Metaregression Framework for Descriptive Epidemiology. 2015. 7. Institute for Health Metrics and Evaluation (2016), Country Profiles. Global health data exchange. Retrieved June 10, 2016, from http://ghdx.healthdata.org/geography/taiwan. 8. Wei, L., Wang, Y., Feng, G.S., Yu, S.C., Duan, Z.P., Lee, M.H., et al., Evaluation of disease burden of hepatitis C in China. Journal of Clinical Virology, 2015. 69: p. 231-231. 9. Liu, Y.H., Liu, G., Ren, X., Zhang, H. and Huang, Y., Disease Burden of Multiple Myeloma in China. Value in Health, 2014. 17(7): p. A727-A727. 10. Mao, Y., Tang, M., Chen, Y. and Wu, S., Disease Burden of Unintended Pregnancy in China. Value in Health, 2014. 17(7): p. A751-A751. 11. Zheng, Z.Z., Fang, X., Yue, N., Wang, B. and Feng, W.W., The Disease Burden among Patients with Psoriasis in China. Value in Health (Impact Factor: 3.28). 11/2012; 15(7):A681. 12. He, M., Ma, J., Wang, D., Chang, J. and Yu, X., The Disease Burden Analysis of 295 Inpatients with Diabetes Mellitus from Tongji Hospital in China. Value in Health, 2010. 13(7): p. A527-A527. 13. Begg, S.J., Vos, T., Barker, B., Stanley, L. and Lopez, A.D., Burden of disease and injury in Australia in the new millennium: measuring health loss from diseases, injuries and risk factors. Med J Aust. 2008 Jan 7;188(1):36-40. 14. Christie, S. and Tobias, M., The burden of infectious disease in New Zealand. Aust N Z J Public Health. 1998 Apr;22(2):257-60. 15. Gane, E.J., Brunton, C.R., Estes, C., Henderson, C., Hornell, J., Radke, S., et al., Hepatitis C Virus (HCV) Infection in New Zealand: Burden of Chronic Disease. Hepatology, 2014. 60: p. 913a-914a. 16. Phua, H.P., Chua, A.V., Ma, S., Heng, D. and Chew, S.K., Singapore's burden of disease and injury 2004. Singapore Med J. 2009 May;50(5):468-78. 17. Park, M.S., Kim, Y.S., Lee, S.H., Kim, S.H., Park, K.H. and Bahk, G.J., Estimating the burden of foodborne disease, South Korea, 2008-2012. Foodborne Pathog Dis. 2015 Mar;12(3):207-13. 18. Kumagai, Y., Gilmour, S., Ota, E., Momose, Y., Onishi, T., Bilano, V.L.F., et al., Estimating the burden of foodborne diseases in Japan. Bull World Health Organ. 2015 Aug 1;93(8):540-549C. 19. Kretzschmar, M., Mangen, M.J., Pinheiro, P., Jahn, B., Fèvre, E.M., Longhi, S., et al., New methodology for estimating the burden of infectious diseases in Europe. PLoS Med. 2012;9(4):e1001205. 20. Mangen, M.J., Plass, D., Havelaar, A.H., Gibbons, C.L., Cassini, A., Mühlberger, N., et al., The pathogen- and incidence-based DALY approach: an appropriate methodology for estimating the burden of infectious diseases. PLoS One. 2013 Nov 20;8(11):e79740. 21. Plass, D., Mangen, M.J., Kraemer, A., Pinheiro, P., Gilsdorf, A., Krause, G., et al., The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the burden of communicable diseases in Europe study. Epidemiol Infect. 2014 Oct;142(10):2024-35. 22. Kothari, V.N. and Gulati, I.S., Disability-Adjusted Life Year as a Guide for Health Policy. Economic and Political Weekly, Vol. 32, No. 41 (Oct. 11-17, 1997), pp. 2612-2617. 23. Meltzer, M.I., Rigau-Pérez, J.G., Clark, G.G., Reiter, P. and Gubler, D.J., Using disability-adjusted life years to assess the economic impact of dengue in Puerto Rico: 1984-1994. Am J Trop Med Hyg August 1998 vol. 59 no. 2 265-271. 24. Morrow, R.H. and Bryant, J.H., Health policy approaches to measuring and valuing human life: conceptual and ethical issues. American Journal of Public Health October 1995: Vol. 85, No. 10, pp. 1356-1360. 25. 衛生福利部統計處, 死因統計。 Retrieved May 30, 2016, from http://www.mohw.gov.tw/CHT/DOS/Statistic.aspx?f_list_no=312&fod_list_no=1610 26. Salomon, J.A., Vos, T., Hogan, D.R., Gagnon, M., Naghavi, M., Mokdad, A., et al., Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet. 2012 Dec 15;380(9859):2129-43. 27. Murray, C.J., Ezzati, M., Flaxman, A.D., Lim, S., Lozano, R., Michaud, C., et al., GBD 2010: design, definitions, and metrics. Lancet 2012; 380: 2063–66. 28. 衛生福利部, 我國加入WHO 2035消除結核第一期計畫。 行政院 104 年 5 月 25 日院臺衛字第 1040027289 號函核定。 29. Lo, H.Y., Yang, S.L., Chou, P., Chuang, J.H. and Chiang, C.Y., Completeness and timeliness of tuberculosis notification in Taiwan. BMC Public Health 2011 12;11:915. Epub 2011 Dec 12. 30. Murray, C.J., Ortblad, K.F., Guinovart, C., Lim, S.S., Wolock, T.M., Roberts, D.A., et al., Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014 Sep 13; 384(9947): 1005–1070. 31. Toman, K. and Frieden, T., Toman's tuberculosis: case detection, treatment and monitoring: questions and answers (2nd edition).2004. 32. Chiang, C.Y., Chang, C.T., Chang, R.E., Li, C.T. and Huang, R.M., Patient and health system delays in the diagnosis and treatment of tuberculosis in Southern Taiwan. Int J Tuberc Lung Dis. 2005 Sep;9(9):1006-12. 33. 方啟泰、王榮德、張郁瑩, 全面雞尾酒療法政策對臺灣愛滋病疫情影響的實證研究。 2003。 34. 莊人祥、李丞華、王大為、王柏堯、黃昭誠、簡慧儀等, 登革熱疾病負擔之估計與應用。 2008。 35. Stanaway, J.D., Shepard, D.S., Undurraga, E.A., Halasa, Y.A., Coffeng, L.E., Brady, O.J., et al., The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016 Feb 10. pii: S1473-3099(16)00026-8. 36. Nguyen-Van-Tam, J.S. and Hampson, A.W., The epidemiology and clinical impact of pandemic influenza. Vaccine. 2003 May 1;21(16):1762-8. 37. Presanis, A.M., De Angelis, D., The New York City Swine Flu Investigation Team, Hagy, A., Reed, C., Riley, S., et al., The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med. 2009 Dec;6(12):e1000207. 38. Chien, Y.S., Su, C.P., Tsai, H.T., Huang, A.S., Lien, C.E., Hung, M.N., et al., Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. J Infect. 2010 Feb;60(2):168-74. 39. The Italian Guillain-Barre Study Group, The prognosis and main prognostic indicators of Guillain-Barré syndrome: a multicentre prospective study of 297 patients. Brain. 1998 Apr;121 ( Pt 4):767-9. 40. Garcı´a-Fulgueiras, A., García-Pina, R., Morant, C., de Larrea-Baz, N.F. and Alvarez, E., Burden of disease related to hepatitis C and hepatitis B in Spain: a methodological challenge of an unfolding health problem. J Viral Hepat. 2011 Oct;18(10):e453-60. 41. Traebert, J., Nickel, D.A., Traebert, E., Escalante, J.J.C. and Schneider, I.J.C., The burden of infectious diseases in the Brazilian Southern state of Santa Catarina. J Infect Public Health. 2016 Mar-Apr;9(2):181-91. 42. Pan, C.Q. and Zhang, J.X., Natural History and Clinical Consequences of Hepatitis B Virus Infection. Int J Med Sci. 2005;2(1):36-40. Epub 2005 Jan 5. 43. Liaw, Y.F. and Chu, C.M., Hepatitis B virus infection. Lancet 2009; 373: 582–92 44. Lo, W.C., Adult Mortality of Non-Communicable Disease and Injury Attributable to Metabolic, Lifestyle, Environmental, and Infectious Risk Factors in Taiwan: A Comparative Risk Assessment. Manuscript sumbitted for publication. (2016). 45. Sung, J.L., Chen, D.S., Lai, M.Y., Yu, J.Y., Wang, T.H., Wang, C.Y., et al., Epidemiological Study on Hepatitis B Virus infection in Taiwan. Chinese J Gastroenterol Vol. 1, No. 1, 1984. 46. 賴世偉、黃金財、李佳霙, 健檢民眾B型及C型肝炎盛行率之描述性分析：以某醫學中心為例。中台灣醫誌 2004;9 Suppl 1:S64-9。 47. Chen, H.F., Li, C.Y., Chen, P., See, T.T. and Lee, H.Y., Seroprevalence of hepatitis B and C in type 2 diabetic patients. J Chin Med Assoc. 2006 Apr;69(4):146-52. 48. Chen, C.H., Yang, P.M., Huang, G.T., Lee, H.S., Sung, J.L. and Sheu, J.C., Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc. 2007 Feb;106(2):148-55. 49. Chen, H.C., You, S.L., Chen, C.J., Wang, C.H. and Yang, C.S., A Preliminary Study on Seroprevalence of Hepatitis C Virus Infection in Taiwan. J Natl Public Health Assoc (ROC): 1992:11 (3):214-220. 50. Sun, C.A., Chen, H.C., Lu, C.F., You, S.L., Mau, Y.C., Ho, M.S., et al., Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol. 1999 Nov;59(3):290-6. 51. Kamal, S.M., Moustafa, K.N., Chen, J., Fehr, J., Abdel Moneim, A., Khalifa, K.E., et al., Duration of peginterferon therapy in acute hepatitis C: a randomized trial. Hepatology. 2006 May;43(5):923-31. 52. Maasoumy, B. and Wedemeyer, H., Natural history of acute and chronic hepatitis C. Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):401-12. 53. Maheshwari, A., Ray, S. and Thuluvath, P.J., Acute hepatitis C. Lancet 2008; 372: 321–32. 54. Powell, D.W., Abramson, B.Z., Balint, J.A., Belle, S., Bloomer, J.R., Diehl, A.K., et al., NIH Consensus Development Conference on Management of Hepatitis C. 1997. 55. Naghavi, M., Wang, H., Lozano, R., Davis, A., Liang, X., Zhou, M., et al., Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015 Jan 10;385(9963):117-71. 56. 王小棋、李佳琳、劉定萍、傅宗襁, 東南亞國家登革熱疫情流行趨勢與分析。衛生福利部疾病管制署, 疫情報導2016; 32(11): 236- 45。 57. 劉英姿、方啟泰、顏哲傑, 2003 至 2013 年台灣地區登革熱併發登革出血熱危險因子分析。台灣衛誌 2015; 34(4): 437- 46。 58. Miyake, Y., Takaki, A., Iwasaki, Y. and Yamamoto, K., Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma. J Viral Hepat. 2010 Apr;17(4):287-92. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/50567 | - |
| dc.description.abstract | 背景：近幾年，因為新興傳染病及再發傳染病的爆發，使得傳染病的發生率大幅度的增加，這嚴重地造成全民健康的威脅。因此，若要有效的分配醫療資源及促進健康政策的制定，對於傳染病的疾病負擔發展出一套全面性的綜合比較分析是必要的。該研究的目的在於依據全球疾病負擔計畫中，疾病負擔推估模式，對全國主要六大傳染病（結核病、愛滋病、B型肝炎、C型肝炎、登革熱、流感）進行失能調整人年(Disability-Adjusted Life Year, DALY)估算。
方法：本研究利用2006至2013年間，臺灣疾病管制署之通報資料庫、健保資料庫、癌症登記資料庫以及全國死因統計檔，推估各目標傳染病之疾病負擔。採用GBD 2010計畫的疾病架構、生命表及失能權重。各疾病的盛行率是由發生率乘上疾病病程推估而來，其中，發生率的推估是來自於修正過低估之後的通報數據。此外，為了有效的計算各傳染病完整的疾病負擔，本研究在計算負擔的時候，亦同時納入了各疾病的急性及慢性併發症。 結果：在2013年，病毒性肝炎在臺灣地區所造成的疾病負擔最高：B型肝炎為每十萬人口758.78 (95% uncertainty interval (UI) 709.17-809.28) DALYs，C型肝炎為每十萬人口296.00 (95%UI 272.96-319.49) DALYs。接著則是慢性傳染病：愛滋病(每十萬人口68.07 DALYs, 95%UI: 63.05-73.98)以及結核病(每十萬人口49.27 DALYs, 95%UI: 48.88-49.65)。急性傳染病是負擔相對較低的疾病：流感為每十萬人口22.74 (95%UI 20.43-29.66) DALYs，登革熱為每十萬人口0.39 (95%UI 0.38-0.41) DALYs。其中，超過98%的病毒性肝炎疾病負擔是來自於慢性併發症(肝硬化及肝癌)。此外，在2006到2013年間，除了目前尚無法治癒的愛滋病之外，慢性傳染病(B型肝炎、C型肝炎及結核病)之疾病負擔逐年下降，而急性傳染病(流感及登革熱)之疾病負擔則是會依據各年度偶發性的流行而起起伏伏。 結論：病毒性肝炎(B型肝炎及C型肝炎)為國內疾病負擔最高之傳染性疾病，其中，絕大部分是來自於它的慢性併發症。因此對於病毒性肝炎的病人而言，長期的照護是很重要的。本篇研究是國內第一篇以一致性方法推估多個傳染病疾病負擔的研究。雖然目前只有以國內六大傳染病為例，但建立了一個推估疾病負擔的範例及基準，可供後續研究者參考，以期將國內各疾病之負擔推估做得更完整。 中文關鍵詞：疾病負擔、傳染病、失能調整人年(DALY)、臺灣 | zh_TW |
| dc.description.abstract | Background: Estimating the burden of infectious diseases is necessary for evidence-based health policy making and prioritization of limited resources. The current study focused on tuberculosis (TB), human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS), hepatitis B virus (HBV) infection, hepatitis C virus (HCV) infection, dengue fever, and influenza.
Methods: The annual disease burden was estimated for the period 2006-2013 for selected infectious diseases in Taiwan using the disability-adjusted life years (DALY) metric. The definition of sequelae and corresponding disability weights for the diseases of interest and the residual life expectancy were obtained from the GBD2010 project. Prevalence estimates were calculated as the incidence multiplied by the duration of disease, whereas the incidence estimates were based on surveillance data corrected for underestimation. We combined both short-term (acute) and long-term (chronic) impacts of diseases in our estimations in order to gain a comprehensive insight into true burden of infectious diseases. Results: Among the six infectious diseases under investigation, viral hepatitis accounted for the largest disease burden in Taiwan in 2013: 758.78 (95% uncertainty interval (UI) 709.17-809.28) DALYs/100,000 population for HBV and 296.00 (95%UI 272.96-319.49) DALYs/100,000 population for HCV respectively. They were followed by HIV/AIDS (68.07 DALYs/100,000 population, 95%UI: 63.05-73.98) and TB (49.27 DALYs/100,000 population, 95%UI: 48.88-49.65). Acute infections of influenza and dengue fever accounted for 22.74 (95%UI 20.43-29.66) and 0.39 (95%UI 0.38-0.41) DALYs/100,000 population in 2013 respectively. The majority (>98%) of the disease burden of viral hepatitis was due to the health loss from chronic complications of cirrhosis and liver cancer, rather than the health loss during acute infection. Moreover, except for lifelong infectious disease of HIV/AIDS, the burden of chronic infectious diseases (HBV, HCV and TB) was declining from 2006 to 2013, while the burden of acute infectious diseases (influenza and dengue fever) were fluctuating. Conclusion: Viral hepatitis (HBV and HCV) are the most burdensome infectious diseases in our estimations, and most of the burden are contributed by their chronic outcomes. As a result, the medical care is important for HBV and HCV patients to reduce long-term complications. Although we only included six major infectious diseases in current research, we established a framework for future assessing the burden of infectious diseases, non-communicable diseases and injuries in Taiwan. Keywords: disease burden; infectious disease; disability adjusted life year (DALY); Taiwan | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T12:46:32Z (GMT). No. of bitstreams: 1 ntu-105-R03849004-1.pdf: 2365969 bytes, checksum: e59cce37aab7d88957dbf3f3305e2c95 (MD5) Previous issue date: 2016 | en |
| dc.description.tableofcontents | Contents
致謝…………………………………………………………………..……………..........i 中文摘要……………………………………………………………………………..….ii Abstract…………………………………………………………………..…………….iv Contents……………………………......……………………………………………….vi List of Figures…………………………………………………...……….………...…...ix List of Tables…………………………………………………………...…..……..……..x Chapter 1 Introduction…………………………………………………………………1 1.1 Infectious diseases in Taiwan…………………………………………………...1 1.2 The Global Burden of Disease project…………………………………………..2 1.3 Problems with data in GBD country-level estimates...………………………….3 1.4 Chronic outcomes of infectious diseases………………………………………..4 1.5 National burden of diseases in other countries………………………………….4 1.6 Research aim……………………………………………………………………5 Chapter 2 Methodology………………………………………………………………...7 2.1 Disease selection………………………………………………………………..7 2.2 GBD cause-sequela-health state structure………………………………………7 2.3 Data sources……………………………………………………………….........8 2.4 General methods for estimating YLD and YLL…………………………………9 2.5 Estimation of prevalence………………………………………………………..9 2.5.1 Tuberculosis……………………………………………………………11 2.5.2 HIV / AIDS……………………………………………………………..11 2.5.3 Dengue fever…………………………………………………………...13 2.5.4 Influenza……………………………………………………………….14 2.5.5 Hepatitis B……………………………………………………………...15 2.5.6 Hepatitis C……………………………………………………………...17 2.6 Estimation of YLL……………………………………………………………..18 2.7 Uncertainty analysis…………………………………………………………...18 Chapter 3 Results……………………………………………………………………...23 3.1 Disease burden of tuberculosis………………………………………………...23 3.2 Disease burden of HIV/AIDS………………………………………………….24 3.3 Disease burden of dengue fever………………………………………………..25 3.4 Disease burden of influenza…………………………………………………...26 3.5 Disease burden of hepatitis B………………………………………………….26 3.6 Disease burden of hepatitis C………………………………………………….27 3.7 Ranking of major infectious diseases in Taiwan………………………………28 Chapter 4 Discussion…………………………………………………………………..39 4.1 Comparison with GBD estimations in Taiwan…………………………………39 4.2 Comparison with other national burden of infectious diseases………………..40 4.3 Chronic sequelae in the burden of infectious diseases…………………………40 4.4 Strengths and limitations………………………………………………………42 4.5 Public health implications……………………………………………………..44 4.6 Conclusions……………………………………………………………………45 Reference………………………………………………………………………………51 Appendix……………………………………………………………………………….61 | |
| dc.language.iso | en | |
| dc.subject | 疾病負擔 | zh_TW |
| dc.subject | 傳染病 | zh_TW |
| dc.subject | 失能調整人年(DALY) | zh_TW |
| dc.subject | 臺灣 | zh_TW |
| dc.subject | 失能調整人年(DALY) | zh_TW |
| dc.subject | 疾病負擔 | zh_TW |
| dc.subject | 傳染病 | zh_TW |
| dc.subject | 臺灣 | zh_TW |
| dc.subject | infectious disease | en |
| dc.subject | disease burden | en |
| dc.subject | infectious disease | en |
| dc.subject | disability adjusted life year (DALY) | en |
| dc.subject | Taiwan | en |
| dc.subject | disease burden | en |
| dc.subject | disability adjusted life year (DALY) | en |
| dc.subject | Taiwan | en |
| dc.title | 推估國內主要傳染性疾病之疾病負擔 | zh_TW |
| dc.title | Burden of Major Infectious Diseases in Taiwan | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 104-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 方啟泰,陳培哲,莊人祥 | |
| dc.subject.keyword | 疾病負擔,傳染病,失能調整人年(DALY),臺灣, | zh_TW |
| dc.subject.keyword | disease burden,infectious disease,disability adjusted life year (DALY),Taiwan, | en |
| dc.relation.page | 95 | |
| dc.identifier.doi | 10.6342/NTU201601248 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2016-07-25 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
| 顯示於系所單位： | 流行病學與預防醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-105-1.pdf 未授權公開取用 | 2.31 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。